YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  
  • Tsetse Genome
  • Virome
  • EyeWire Banner
  • 23 and Me
  • Toumazou
  • DeepGenomics
New Products and Announcements at the American Society of Human Genetics Meeting
| Bio-IT World | Companies including Illumina, Complete Genomics, Pacific Biosciences, Invitae, QIAGEN, and DNAnexus gathered this week at the annual meeting of the American Society of Human Genetics in Baltimore to show off their latest products and services. more

Amazon wants companies to get onto its cloud using new services
| Computerworld | Amazon launched a handful of new services all aimed at getting companies onto its cloud platform Wednesday, including a new ruggedized box for shipping data to the cloud provider. more

Estonia Is Embracing Personalized Medicine With Its DNA Biobank
| The Atlantic | The country's genetic biobank is still in its earliest stages, but the government hopes to one day have enough donors to totally overhaul its health-care system. more

GENALICE Launches Population Calling Analysis Module
| Bio-IT World In a live webinar today, GENALICE launched the Population Calling analysis module to their GENALICE MAP Next-Generation Sequencing (NGS) Data Analysis Suite. In partnership with Mount Sinai Hospital, Amazon Web Services, and Intel, GENALICE processed the whole genomes of 800 patients from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), an Alzheimer’s disease cohort during the webinar. more

GSK Updates on Social Media Tracking
| MobiHealthNews | GlaxoSmithKline and Epidemico won a 2015 Bio-IT World Best Practices award last year for ProjectCRAWL, an effort to survey social media to alert GSK to adverse events. Yesterday, GSK's director of pharmacovigilance gave an update on how the pharma is using Epidemico's data. more

City of Hope Turns to PFS Clinical to Mitigate Regulatory and Financial Risk with Clinical Research Coverage Analysis and Budget Standardization
| MIDDLETON, WI - Oct 7, 2015 - PFS Clinical, which offers turnkey administrative solutions that address the key pain points of establishing and running a clinical trial office, has been engaged by City of Hope to provide Coverage Analysis (CA) to ensure its clinical research trials remain compliant with complex Medicare billing regulations more

Emergency Dentist USA Annouces Partnership with 1800-Dentist
| LINCOLN, NE, UNITED STATES - Oct 7, 0015 - City, STATE – October 5, 2015 – Emergency Dentist USA is proud and honored to announce its partnership with 1800-Dentist more

Smart pills transforming the diagnostics and healthcare market
| PORTLAND, OR, UNITED STATES - Oct 7, 2015 - Smart pills are ingestible medical devices consisting of elements such as sensors, cameras, patches and trackers that help in better diagnostics and monitoring more

BC Platforms Launches Personalized Precision Medicine Initiative with the University of Colorado Anschutz Medical Campus
| HELSINKI, FINLAND - Oct 6, 2015 - BC Platforms, a world leader in genomic data management solutions, today announced that the University of Colorado Anschutz Medical Campus will use the company’s world-leading, comprehensive data management program to support  the launch of the university’s new personalized medicine initiative aiming at translating community genomics into individual well-being more

Genomics England announces Congenica as an interpretation partner as it expands industry engagement
| CAMBRIDGE, UK - Sep 30, 2015 - Tom Weaver, CEO of Cambridge-based Congenica is delighted that its technology is reaching patients and says; “One of the aims of Genomics England is to enable NHS patients to gain early benefit from advances in genomics and through participation in the 100,000 Genomes Project we have been able to accelerate development of our Sapientia™ diagnostic platform more

| CAMBRIDGE UK, UK - Sep 29, 2015 - Life Sciences Minister George Freeman MP today announced at the GREAT Healthcare Week at the Milan Expo, that Congenica, a world leading developer of genome-based discovery and diagnostic technologies, has been awarded £300,000 by Innovate UK as part of its ‘Finding value in complex data’ competition more

Affordable large-scale DNA variation studies for every DNA researcher
| HARDERWIJK, THE NETHERLANDS - Sep 24, 2015 - Today, GENALICE announced the global launch date of Population Calling, a new analysis module and part of their GENALICE MAP Next-Generation Sequencing (NGS) Data Analysis Suite more

CSM to Celebrate Grand Opening of New Malvern Facility
| MALVERN, PA - Sep 17, 2015 - CSM is pleased to announce that it will hold a Grand Opening and Ribbon-Cutting ceremony for its newly constructed facility at 300 Technology Drive in the Great Valley Corporate Center of Malvern, Pennsylvania on Thursday, October 15th from 1 p more

Bio-specimen Grant Program Launched
| MINNEAPOLIS, MN, UNITED STATES - Sep 14, 2015 - DaVita Clinical Research® (DCR®), a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its Biospecimen ResearchGrant Program (BioReG), a grant program to award clinical-trial-quality biospecimens and annotated de-identified data to academic medical centers involved in kidney research more

Genedata at SBI2 will Showcase How Genedata Screener Industrializes HCS
| CAMBRIDGE, MA, UNITED STATES - Sep 14, 2015 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, announced it will be among the presenters at the 2nd Annual Society of Biomolecular Imaging and Informatics (SBI2) Meeting more



For more than a decade, MarkLogic has delivered a powerful, agile, and trusted Enterprise NoSQL database platform that enables organizations to turn all data into valuable and actionable information. Organizations around the world rely on MarkLogic’s enterprise grade technology to power the new generation of information applications. MarkLogic is headquartered in Silicon Valley and has offices throughout the U.S., Europe, Asia, and Australia.
For more information, please visit

Thermo Fisher Scientific

GeneArt™ Platinum Cas9 Nuclease
Maximum efficiency, minimal off-target cleavage

New GeneArt Platinum Cas9 Nuclease is wild type Cas9 in protein format for genome editing with CRISPR-Cas9 technology. Platinum Cas9 protein and guide RNA forms a very stable ribonucleotideprotein (RNP) complex that provides the next level of cleavage efficiency over CRISPR-Cas9 vector and mRNA systems. The Cas9 RNP complex can act immediately after it enters the cell since transcription and translation are not required and is rapidly cleared from the cell, minimizing the chance for off-target cleavage events when compared to vector-based systems. The Cas9 protein is microinjection ready with NLS.

Bio IT World Lead Gen  

Upcoming Industry Events and Webinars

 Upcoming Webinars  

Data Integration in Life Science – Are You Ready? |
Thu, May 1 at 1 pm EST | Sponsored by YarcData  

Ready...Set...Collaborate--Saving Millions with Faster Time to Market |
Thu, May 15 at 11 am EST | Sponsored by Exostar 

Redefining Targeted Sequencing: Complete Coverage of Targeted Regions via an Innovative Massively-Parallel Singleplex PCR Enrichment |

Wed, May 28 at 1 pm EST | Sponsored by Wafergen

Genome-Phenome Analysis |
Wed, June 25 at 1 pm EST  | Sponsored by SimulConsult

Recorded Webinars 

How TGen is Applying High Performance Computing to Accelerate Cancer Research 
Sponsored by Terascala

An Integrated Platform for All Translational Medicine Data: Using Visual Analytics and Tibco Spotfire to Enhance Personalized Medicine and Translational Science  
Sponsored by PerkinElmer 

Trends in BioIT Data Management & Storage 
Sponsored by Avere Systems 

Big Bioinformatics and Healthcare Analytics without Big Hassles 
Sponsored by Paradigm4

Manage Complexity by Visual Data Exploration 
Sponsored by Qlucore

Digital Signatures in the Enterprise
Sponsored by ARX 

Complete Webinar Listing 


Upcoming Events 

Bio-IT World Conference & Expo
April 29- May 1, 2014 • Boston, MA

BIOtech 2014 in Japan
May 14-16, 2014  • Tokyo, Japan

2nd Annual Next Generation Sequencing Data Congress
May 19-20, 2014 • London, UK

14th Annual Structure-Based Drug Design
May 21-22, 2014 • Boston, MA

15th Annual Drug Discovery Leaders Summit 2014
June 2-3, 2014 • Geneva, Switzerland

6th Annual Drug Development Congress 2014
June 2-3, 2014 • Geneva, Switzerland

2nd Annual Discovery Chemistry & Drug Design Congress 2014
June 2-3, 2014 • Geneva, Switzerland

Conference on Translational Medicine
September 22-25, 2014 • Vienna, Austria

4th Annual Next Generation Sequencing Asia Congress 2014
October 7-8, 2014 • Singapore

2nd Annual Single Cell Genomics & Transcriptomics Asia Congress 2014
October 7-8, 2014 • Singapore

6th Annual Next Generation Sequencing Congress 2014
November 2014 • UK


Complete Event Listing 

Free Downloads: Whitepapers, Podcasts and More


Related Products

BIOVIA’s ScienceCloud  BIOVIA’s ScienceCloud 

The BIOVIA Biologics Solution  The BIOVIA Biologics Solution 

Using Text Mining to Discover Repositioning Opportunities for Orphan Drugs and Rare Diseases

November 13 at 11am EST  |  Register Today to Reserve Your Space Sponsored by    It is no surprise that authors place what they consider to be their most important and promising findings into an abstract. But as an abstract’s size

For reprints and/or copyright permission, please contact Terry Manning, 781.972.1349.